Study to Investigate Hepatic Impairment on PK, Safety, Tolerability of Camizestrant in Post-Menopausal Female Subjects
Clinical trial NCT05790304 · COMPLETED
Trial details
- NCT number
- NCT05790304
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-20
- Primary completion
- 2024-02-22
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.